|
References | Time to recurrence (years) | Age of first treatment | Stage | Initial treatment | Histological type | Recurrence site | Treatment | DFP (months) |
|
Zylberberg et al. [7] (3 cases) | 21 | 33 | IIIC | TAH+BSO+OM+excision of visible masses→ten cycles of monthly adjuvant chemotherapy (intraperitoneal and intravenously) | Serous | Appendix | Appendectomy, suboptimal cytoreduction, and chemotherapy | 37 |
21 | 50 | IC | TAH+BSO+OM, adjuvant chemotherapy | Lower axilla, hepatic nodules, diffuse peritoneal carcinomatosis, and bone metastases | Chemotherapy | 19 |
26 | 32 | IIIC | Complete cytoreduction, adjuvant chemotherapy, and radiotherapy | Para-aortic lymph node | Laparotomy excision of the mass | 36 |
|
Sahdev et al. [1] (4 cases) | Ungiven, include a case of 31 years | NA | I, I, IIIC, and unknown | NA | NA | Of 4 cases, 4 pelvic mass, 2 peritoneal, 2 nodal, 2 serosal and mesenteric, 2 ascites, and visceral | Chemotherapy | NA |
|
Testelmans et al. [8] | 23 | 36 | NA | TAH+USO and adjuvant chemotherapy | Serous papillary ovarian carcinoma | Thoracic wall | Cytoreduction of the right posterior dorsal thoracic wall, part of the diaphragm, azygos vein, thoracic duct, sympathetic chain, and mediastinal fat; mediastinal lymph node dissection; and local radiotherapy to the mediastinum and the posterior thoracic wall | 12 |
|
Izuishi et al. [9] | 20 | 32 | IIC | TAH+BSO and adjuvant chemotherapy; a year later, second-look surgery, low anterior resection, and adjuvant chemotherapy | Serous papillary adenocarcinoma contained components of a poorly differentiated adenocarcinoma | Spleen | Splenectomy | 60 |
|
Menczer et al. [10] | 28 | 22 | IIIC | TAH+BSO+pOM, adjuvant chemotherapy 1 year after, and “second-look” operation | Serous | Para-aortic retroperitoneal mass | Complete cytoreduction | NA |
|
Otsuka and Shoji [11] | 25 | 29 | I | USO (right) during the first trimester of the pregnancy, spontaneous abortion after surgery, adjuvant chemotherapy, and TAH+USO (left) | High-grade endometrioid carcinoma with areas of serous histology | Para-aortic lymph node | Para-aortic lymph node resection, chemotherapy, and radiation | 107 |
|
Inoue et al. [12] | 29 | 38 | III | Radical hysterectomy+OM and adjuvant chemotherapy | Serous | Lung, anterior mediastinum, and liver | VATS, chemotherapy, and subsequently bevacizumab alone | 12 |
|
Omura et al. [13] | 31 | 23 | NA | BSO; 2 years later, uterine metastasis, extended hysterectomy, and adjuvant chemotherapy | Low-grade serous | Thymic epithelial tumor | Partial thymectomy | 19 |
|
Chiba et al. [14] | 41 | 38 | IC | TAH+BSO+pOM and adjuvant chemotherapy | Low-grade serous | Pancreas and liver | Chemotherapy | NA |
|
Takagi et al. [15] | 30 | 46 | NA | Radical hysterectomy and adjuvant chemotherapy | High-grade serous | Spleen, peritoneal dissemination, para-aortic and Virchow lymph nodes, intestine, and pouch of Douglas | Partial resection of the intestine; other not mentioned | NA |
|
Current case | 18 | 57 | IC | TAH+BSO+pOM and adjuvant chemotherapy | High-grade serous | Spleen and liver | Chemotherapy, hepatic resection (right lobe; segments 5, 6, and 8+splenectomy+cholecystectomy) and adjuvant chemotherapy | 56 |
|